Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Peritoneal Malignant Mesothelioma”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Large-scale testing (Phase 3)UnknownNCT00003034
What this trial is testing

ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen

Who this might be right for
Malignant Mesothelioma
Alfacell 300
Early research (Phase 1)Study completedNCT00055705
What this trial is testing

PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Not applicableEnded earlyNCT01271959
What this trial is testing

ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study

Who this might be right for
Solid Organ Tumors
Precision Therapeutics 167
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Not applicableEnded earlyNCT00028782
What this trial is testing

EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer

Who this might be right for
Advanced Malignant MesotheliomaLocalized Malignant MesotheliomaMalignant Ascites+2 more
National Cancer Institute (NCI) 80
Early research (Phase 1)Study completedNCT00398138
What this trial is testing

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma

Who this might be right for
LeukemiaLung CancerMalignant Mesothelioma+2 more
Memorial Sloan Kettering Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT02399371
What this trial is testing

Pembrolizumab in Treating Patients With Malignant Mesothelioma

Who this might be right for
Biphasic MesotheliomaEpithelioid MesotheliomaPeritoneal Malignant Mesothelioma+7 more
University of Chicago 65
Early research (Phase 1)Study completedNCT03507452
What this trial is testing

First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin

Who this might be right for
Advanced Recurrent Malignant Pleural Epithelioid MesotheliomaAdvanced Recurrent Malignant Peritoneal Epithelioid MesotheliomaAdvanced Recurrent Serous Ovarian Cancer+1 more
Bayer 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT03074513
What this trial is testing

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

Who this might be right for
Appendix AdenocarcinomaHuman Papillomavirus-Related Anal Squamous Cell CarcinomaHuman Papillomavirus-Related Cervical Squamous Cell Carcinoma+18 more
M.D. Anderson Cancer Center 133
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00003046
What this trial is testing

Interleukin-12 in Treating Patients With Cancer in the Abdomen

Who this might be right for
Anal CancerColorectal CancerGallbladder Cancer+2 more
M.D. Anderson Cancer Center 29
Early research (Phase 1)Looking for participantsNCT07277413
What this trial is testing

IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Who this might be right for
NSCLC AdenocarcinomaGastroesophageal Cancer (GC)Gastric Adenocarcinoma+10 more
IDEAYA Biosciences 260
Testing effectiveness (Phase 2)Active Not RecruitingNCT02535312
What this trial is testing

Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin

Who this might be right for
Advanced Malignant Solid NeoplasmAdvanced Peritoneal Malignant MesotheliomaAdvanced Pleural Malignant Mesothelioma+4 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00066651
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT03907852
What this trial is testing

Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer

Who this might be right for
MesotheliomaMesothelioma, MalignantMesothelioma; Pleura+8 more
TCR2 Therapeutics 57
Early research (Phase 1)Looking for participantsNCT06756035
What this trial is testing

CT-95 in Advanced Cancers Associated With Mesothelin Expression

Who this might be right for
Mesothelin-Expressing TumorsEpithelial Ovarian CancerMalignant Pleural Mesothelioma, Advanced+8 more
Context Therapeutics Inc. 70
Early research (Phase 1)Study completedNCT00006981
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT05455424
What this trial is testing

Niraparib Efficacy in Patient With Unresectable Mesothelioma

Who this might be right for
Mesothelioma, Malignant
University Hospital Southampton NHS Foundation Trust 88
Early research (Phase 1)Ended earlyNCT03608618
What this trial is testing

Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma

Who this might be right for
Peritoneal MesotheliomaFallopian Tube AdenocarcinomaAdenocarcinoma of the Ovary+1 more
MaxCyte, Inc. 14
Very early researchEnded earlyNCT04213794
What this trial is testing

Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients

Who this might be right for
Malignant Abdominal NeoplasmMalignant Pelvic NeoplasmRecurrent Colon Carcinoma+24 more
Mayo Clinic 2
Next Page
30